WASHINGTON, June 20 -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin and PhRMA Board Chairman David Brennan, Chief Executive Officer, AstraZeneca, issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback